Resumen Stereotactic Body Radiosurgery (SBRT) in Non-Surgical Lung Cancer
Introduction: In 2020, localized lung cancer was diagnosed in 4 million people, of whom 1.4 …

Objective Stereotactic body radiation therapy is the preferred treatment modality for patients
with inoperable early-stage non–small cell lung cancer. However, comparative outcomes …

Objective: To evaluate the efficacy of stereotactic body radiotherapy (SBRT) versus surgery
for early-stage non-small cell lung cancer (NSCLC) by means of a meta-analysis of …

Introduction Lung cancer is the most frequent neoplasm in humans. Surgery is considered
the best therapeutic approach for stage I non-small lung cell cancer (NSCLC). However, a …

Background Stereotactic body radiation therapy (SBRT) is the preferred treatment modality
for patients with inoperable early-stage NSCLC. However, comparative outcomes of SBRT …

Purpose A population-based matched-pair comparison was performed to compare the
efficacy of stereotactic body radiotherapy (SBRT) versus surgery for early-stage non-small …

Background Surgery is the gold standard therapy for patients with early-stage non–small-
cell lung cancer (NSCLC). However, stereotactic body radiotherapy (SBRT) may provide as …

Objective Stereotactic body radiotherapy is the standard treatment for medically inoperable
early-stage non–small cell lung cancer. Recent data suggest that in operable patients …

Background Virtually all patients with medically inoperable stage I non-small cell lung
cancer (NSCLC) can receive stereotactic body radiation therapy. However, the percentage …

Lung cancer, the second most frequently diagnosed malignancy for men and women in the
United States, will account for an estimated 221,200 newly diagnosed cases and 158,040 …